Trademarkia Logo

Canada

C$
Trademark Search in Canada
Klickmer

View On IC.GC.CA

Klickmer
ADVERTISED

on 22 Nov 2024

Last Applicant/ Owned by

Immudex ApS

Bredevej 2ADK-2830 Virum

DK

Serial Number

2109742 filed on 5th Feb 2021

Registration Number

TMA1270978 registered on 22nd Nov 2024

Registration expiry Date

5th Feb 2031

Correspondent Address

FURMAN IP LAW & STRATEGY PC

260-10 Research DriveOffice D/EREGINA

SASKATCHEWAN

CA

S4S7J7

Klickmer

Trademark usage description

chemicals used in medical diagnostics and treatment in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, tb vaccines, hiv-v Read More

Classification Information

Class [001]
Chemicals used in medical diagnostics and treatment in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; diagnostic preparations for medical scientific research use; diagnostic reagents for medical-scientific research use; diagnostic reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; research reagents for use in medical diagnostics applications in the field of vaccines and Immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; diagnostic test materials for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumours and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; diagnostic kits for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TBvaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; assays for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TBvaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; biochemical reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TBvaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumours and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue; preparations for analysis for research purposes related to analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; chemical reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TBvaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring.

Classification kind code

11

Class [005]
Preparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes for use in the diagnosis and treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; reagents for medical and veterinary purposes for use in the diagnosis and treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious disease; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccines, immunotherapeutics and cellular therapies, cancer vaccines and immunotherapeutics, borrelia vaccines, TB vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy and other therapy, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, infectious diseases; chemical preparations for analysis for medical diagnostic purposes, in relation to organ transplantation, immune monitoring, and vaccines and T-cell monitoring.

Classification kind code

11

Mark Details

Serial Number

2109742

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 26th Jan 2023		Agent Changed
Submitted for opposition 22
on 13th Sept 2022		Search Recorded
Submitted for opposition 20
on 13th Sept 2022		Examiner's First Report
Submitted for opposition 223
on 13th Sept 2022		Total Provisional Refusal
Submitted for opposition 256
on 28th Mar 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 27th May 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 26th May 2021		Formalized
Submitted for opposition 1
on 26th May 2021		Created
Submitted for opposition 228
on 5th Feb 2021		International Registration
Submitted for opposition 30
on 5th Feb 2021		Filed